Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert Allen Northey currently holds 8,082 shares of Sonoma Pharmaceuticals, Inc. (SNOA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Allen Northey has been a net neutral trader of SNOA stock. They have purchased $0 and sold $0 worth of shares.
Robert Allen Northey's most recent insider trade was on Jun 29, 2017, when they sold 3,404 shares at $0.00 per share.
Robert Allen Northey serves as Executive at Sonoma Pharmaceuticals, Inc. (SNOA). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Robert Allen Northey holds the position of Executive at Sonoma Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Robert Allen Northey has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Robert Allen Northey was on Nov 30, 2016, when they purchased $22.5K worth of OCLS shares. This transaction involved 4,678 shares at $4.81 per share.
Robert Allen Northey currently owns 8,082 shares of Sonoma Pharmaceuticals, Inc. (SNOA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert Allen Northey's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert Allen Northey has 2 Form 4 filings on record as an insider at Sonoma Pharmaceuticals, Inc..
Set alerts for Robert Allen Northey and 40,000+ other insiders.